ExellenS™ is Samsung Biologics’ standardized
biomanufacturing framework, applied consistently
across all sites to ensure plant-to-plant equivalency and
speed. Our unique, proven approach combines biologics
and technological expertise to eliminate inefficiencies.
The result is faster, more predictable processes and
consistent delivery that our clients can rely on.
Designed for Speed. Standardized for Reliability.
-
- Rapid approvals
-
Equivalency across
multiple plants accelerates regulatory approvals
-
- Predictable outcomes
-
Consistent systems reduce
risk and ensure stable delivery of client programs
-
- Streamlined processes
-
Standardized bioreactor
configuration and processes maximize efficiency
-
- Speed to market
-
Agile tech transfers enable
rapid scale-up and faster product launches
-
- Data-driven insights
-
Unified digital platforms
support best-scenario modeling and smarter decisions
Future-proof Your Pipeline with Scalable Platforms for Any Modality

With dual downstream capability and harmonized platforms, ExellenS™ enables fast-track technology transfers across plants while ensuring predictable, consistent delivery.
Our global manufacturing network is designed to accommodate diverse modalities, balance production schedules, and enable multi-sourcing flexibility for stronger supply chain resilience.
-
Built on Our
Four Pillars of Excellence-
Predictable outcomes and risk reduction at every stage.
-
Consistent, uncompromising quality that meets the highest global standards.
-
Optimized processes ensuring reliability, reproducibility, and flexibility.
-
Highly trained professionals empowered by unified standards and systems.
-
Guided by the
Three Structural Principles-
A unified blueprint across every plant, implementing identical facility design, digital processes, and seamless performance.
-
Streamlined operations that minimize complexity at every stage, delivering faster tech transfers, minimized risks, and greater efficiency.
-
Global adaptability and integration of new capabilities, giving clients access to expanded capabilities without disruption.
Related Content